Tag: companies
Intercept’s NASH hopeful spurned by FDA, raising questions for other companies...
Intercept Therapeutics, long the frontrunner in non-alcoholic steatohepatitis (NASH), has suffered several delays on its FDA application for obeticholic acid (OCA). Now, the company has received an...
States file 3rd generics price-fixing suit, alleging ‘multibillion-dollar fraud’ by 26...
Years after states filed an initial price-fixing lawsuit against generics companies—led by the office of the Connecticut attorney general—they’re not letting up. In fact,...
